tlooto

Long-Term Evolution of Disease Behavior of Crohn's Disease

J. Cosnes, S. Cattan, A. Blain, L. Beaugerie, F. Carbonnel, R. Parc, J. Gendre

2002.7.1Inflammatory Bowel Diseases

Paper details

Journal
Inflammatory Bowel Diseases
Published
2002.7.1
Citations
1,336
References
22
Access
Open Access
Fields
Medicine

tlooto Summary

Most patients with CD will eventually one day develop a stricturing or a perforating complication, and initial location determines the type of the complication.

Abstract

BackgroundThe Vienna classification of Crohn's disease (CD) distinguishes three patient subgroups according to disease behavior: stricturing, penetrating, and inflammatory. Our aim was to assess the long-term evolution of the disease behavior of CD and to determine the predictive factors and prognostic implications of this evolution. MethodsOccurrence and predictive factors of a stricturing and/or a penetrating complication were searched for in 2,002 patients with CD studied retrospectively. In addition, the 1995–2000 disease course was assessed prospectively in a cohort of 646 patients with disease duration >5 years, classified according to their previous disease behavior. Results1,199 patients (60%) developed a stricturing (n = 254) or a penetrating (n = 945) complication. Twenty-year actuarial rates of inflammatory, stricturing, and penetrating disease were 12, 18, and 70%, respectively. The initial location of lesions was the main determinant of the time and type of the complication. In the cohort study, year-by-year activity and therapeutic requirements did not show significant sustained differences between behavioral subgroups. ConclusionMost patients with CD will eventually one day develop a stricturing or a perforating complication. Initial location determines the type of the complication. Classification of patients into a behavioral group from previous history has no impact upon activity during the following years.

Citation format

COSNES, J., et al. Long-term evolution of disease behavior of crohn's disease. Inflammatory Bowel Diseases, 2002, 8(4): 244–250.